Literature DB >> 26797349

MRI Features of Mucinous Cancer of the Breast: Correlation With Pathologic Findings and Other Imaging Methods.

Almir G V Bitencourt1, Luciana Graziano1, Cynthia A B T Osório2, Camila S Guatelli1, Juliana A Souza1, Maria Helena S Mendonça3, Elvira F Marques1.   

Abstract

OBJECTIVE: Mucinous breast carcinoma is an uncommon histologic type of invasive breast carcinoma that can be differentiated in pure and mixed forms, which have different prognosis and treatment.
CONCLUSION: MRI features of both types of mucinous breast carcinomas are discussed, illustrated, and compared with pathologic findings and with other imaging methods, including mammography, ultrasound, and PET/CT.

Entities:  

Keywords:  MRI; breast neoplasms; mucinous neoplasms

Mesh:

Year:  2016        PMID: 26797349     DOI: 10.2214/AJR.15.14851

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Focal breast lesion characterization according to the BI-RADS US lexicon: role of a computer-aided decision-making support.

Authors:  Tommaso Vincenzo Bartolotta; Alessia Orlando; Vito Cantisani; Domenica Matranga; Raffele Ienzi; Alessandra Cirino; Francesco Amato; Maria Laura Di Vittorio; Massimo Midiri; Roberto Lagalla
Journal:  Radiol Med       Date:  2018-03-22       Impact factor: 3.469

2.  Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes.

Authors:  Selman Emiroglu; Mustafa Tukenmez; Seyma Karakus; Hasan Karanlik; Semen Onder; Vahit Ozmen; Neslihan Cabioglu; Enver Ozkurt; Ravza Yilmaz; Mahmut Muslumanoglu
Journal:  Eur J Breast Health       Date:  2022-10-01

3.  Can diffusion-weighted imaging add information in the evaluation of breast lesions considered suspicious on magnetic resonance imaging?

Authors:  Camila Souza Guatelli; Almir Galvão Vieira Bitencourt; Cynthia Aparecida Bueno de Toledo Osório; Luciana Graziano; Alessandra Araújo de Castro; Juliana Alves de Souza; Elvira Ferreira Marques; Rubens Chojniak
Journal:  Radiol Bras       Date:  2017 Sep-Oct

4.  Colonic mucinous adenocarcinoma causing intussusception and distant metastasis: A case report.

Authors:  Xiaohui Xu; Zhiyuan Kong; Ke Yi; Bing Wang; Qingjun Lei; Yi Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Mucinous carcinoma of the breast: Diagnosis and management of an unusually young patient.

Authors:  Denny Marcela Achicanoy Puchana; Fabricio Andres Lasso Andrade; Diana Fernanda Achicanoy Puchana; María Alejandra Boada Fuentes; María Alejandra Álvarez Duarte; Karolayn Angarita Acuña; Andrea Carolina Jaime Aguirre; Jessica Alejandra Muñoz Murillo; Amanda Mercedes González Lago; Daniel Andres Alegria Cuellar; Luisa Katherine Orozco Morales; Migdalia Zamirna Zuleny Lasso Anacona; Alex Efren Alvarado Rengifo; Jose Rafael Rosero Rosero
Journal:  Radiol Case Rep       Date:  2022-03-02

6.  Using Ultrasound-Based Multilayer Perceptron to Differentiate Early Breast Mucinous Cancer and its Subtypes From Fibroadenoma.

Authors:  Ting Liang; Junhui Shen; Shumei Zhang; Shuzhen Cong; Juanjuan Liu; Shufang Pei; Shiyao Shang; Chunwang Huang
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

7.  Multifocal invasive mucinous carcinoma of the breast.

Authors:  Melissa J Ferguson
Journal:  J Med Radiat Sci       Date:  2020-01-23

Review 8.  Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis.

Authors:  Emilia Marrazzo; Federico Frusone; Flavio Milana; Andrea Sagona; Wolfgang Gatzemeier; Erika Barbieri; Alberto Bottini; Giuseppe Canavese; Arianna Olga Rubino; Marco Gaetano Eboli; Carlo Marco Rossetti; Alberto Testori; Valentina Errico; Alessandro De Luca; Corrado Tinterri
Journal:  Breast       Date:  2019-11-11       Impact factor: 4.380

9.  Application of MRI Radiomics-Based Machine Learning Model to Improve Contralateral BI-RADS 4 Lesion Assessment.

Authors:  Wen Hao; Jing Gong; Shengping Wang; Hui Zhu; Bin Zhao; Weijun Peng
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.